Silexion Therapeutics

SLXN • XNAS

Silexion Therapeutics is a biological products, (no disgnostic substances) company trading on XNAS, led by CEO Ilan Hadar, with a market cap of $4.1M.

CEOIlan Hadar

Market Cap$4.1M

BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Websitesilexion.com

Next Earnings

Upcoming earnings announcement for Silexion Therapeutics

Date

Tuesday, May 12, 2026 (in a month)

Timing

After Market Close (4:00 PM New York)

Fiscal Period

Q1 2026

Earnings History

Past 7 earnings reports for Silexion Therapeutics

Date	Period	EPS	EPS Surprise	Revenue	Rev. Surprise	Filing
Mar 17, 2026	Q4 2025	-$1.40Est: -$1.14	-22.8%	-	—	—
Nov 12, 2025	Q3 2025	-$2.88	—	-	—	10-Q
Aug 12, 2025	Q2 2025	-$4.32	—	-	—	10-Q
May 13, 2025	Q1 2025	-$0.26	—	-	—	10-Q
Mar 18, 2025	Q4 2024	$14.24	—	-	—	10-K
Nov 14, 2024	Q3 2024	-$18.27	—	-	—	10-Q
Aug 29, 2024	Q2 2024	-$52.83	—	-	—	10-Q

View all filings on SEC EDGAR

Silexion Therapeutics

Next Earnings

Earnings History

Cookie Preferences